No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534751 | PMC |
| http://dx.doi.org/10.1016/j.jmii.2020.09.003 | DOI Listing |
Publication Analysis
Top Keywords
triple therapy
8
therapy hydroxychloroquine
8
hydroxychloroquine azithromycin
8
azithromycin ciclesonide
8
covid-19 pneumonia
8
ciclesonide covid-19
4
pneumonia specific
4
specific therapy
4
therapy covid-19
4
covid-19 report
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!